Prognostic value of the triglyceride-glucose (TyG) index for renal function progression in patients with CKD stages 3–4 (opens in new tab)

BackgroundThe progression of chronic kidney disease (CKD) is a major public health issue. Insulin resistance (IR) is a key mechanism, but simple biomarkers to predict progression in patients with established CKD stages 3–4 are needed. The Triglyceride-glucose (TyG) index is a reliable surrogate for IR. We aimed to investigate the longitudinal association between the baseline TyG index and the risk of renal function progression in patients with CKD stages 3–4.MethodsThis multicenter retrospect...